Mark A Glickman - Net Worth and Insider Trading

Over the past 18 months, Mark A Glickman made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,679 shares made by Eric Warren , a net sale of 4,202 shares made by Joanne M. Foody , and a net sale of 14,550 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 17,476 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 17,476 shares. During the past 18 months, 26,431 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,431 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Old API Wind-down Ltd (ARLZQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Old API Wind-down Ltd (ARLZQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Old API Wind-down Ltd (ARLZQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Mark A Glickman made no insider transaction in TherapeuticsMD Inc (TXMD). Other recent insider transactions involving TherapeuticsMD Inc (TXMD) include a net purchase of 5,294 shares made by Collins Cooper C. , and a net sale of 19,050 shares made by Marlan D Walker .

In summary, during the past 3 months, insiders sold 0 shares of TherapeuticsMD Inc (TXMD) in total and bought 5,294 shares, with a net purchase of 5,294 shares. During the past 18 months, 19,050 shares of TherapeuticsMD Inc (TXMD) were sold and 5,294 shares were bought by its insiders, resulting in a net sale of 13,756 shares.

TherapeuticsMD Inc (TXMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Mark A Glickman made no insider transaction in NeuroBo Pharmaceuticals Inc (NRBO). Other recent insider transactions involving NeuroBo Pharmaceuticals Inc (NRBO) include a net purchase of 5,088,653 shares made by Dong-a St Co., Ltd ,

In summary, during the past 3 months, insiders sold 407 shares of NeuroBo Pharmaceuticals Inc (NRBO) in total and bought 0 shares, with a net sale of 407 shares. During the past 18 months, 407 shares of NeuroBo Pharmaceuticals Inc (NRBO) were sold and 5,089,060 shares were bought by its insiders, resulting in a net purchase of 5,088,653 shares.

NeuroBo Pharmaceuticals Inc (NRBO)'s detailed insider trading history can be found in Insider Trading Tracker table.